Protein Modification Reagents
Search Within Results
4,696
–
4,710
of
5,663
results
4,696
4,697
4,698
4,699
4,700
4,701
4,702
4,703
4,704
4,705
4,706
4,707
4,708
4,709
4,710
Medchemexpress LLC Dbco-PEG4-VC-PAB-MMAE | 2129164-91-4 | 99.2% | 1658.03 | C88H128N12O19 | 100 MG
DBCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate combining a DBCO click handle, a PEG4 spacer, a valine-citrulline-p-aminobenzyl cleavable linker, and the cytotoxic monomethyl auristatin E payload. It is intended for research use in synthesizing antibody-drug conjugates via strain-promoted alkyne-azide cycloaddition.
- Used for strain-promoted alkyne-azide cycloaddition (SPAAC) conjugation.
- Contains a PEG4 spacer for increased hydrophilicity.
- Includes a valine-citrulline-p-aminobenzyl cleavable linker for intracellular release.
- Incorporates monomethyl auristatin E as the cytotoxic payload.
- High purity (99.18%).
- Soluble in DMSO at 150 mg/mL; may require ultrasonic assistance.
- Supplied as a powder; unstable in solution, store at -20°C and prepare fresh solutions.
